196 related articles for article (PubMed ID: 31268295)
1. Modeling Barrier Properties of Intestinal Mucus Reinforced with IgG and Secretory IgA against Motile Bacteria.
Xu F; Newby JM; Schiller JL; Schroeder HA; Wessler T; Chen A; Forest MG; Lai SK
ACS Infect Dis; 2019 Sep; 5(9):1570-1580. PubMed ID: 31268295
[TBL] [Abstract][Full Text] [Related]
2. Mucosal barrier mechanisms. Interplay between secretory IgA (SIgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes.
Magnusson KE; Stjernström I
Immunology; 1982 Feb; 45(2):239-48. PubMed ID: 7037617
[TBL] [Abstract][Full Text] [Related]
3. Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus.
Wessler T; Chen A; McKinley SA; Cone R; Forest G; Lai SK
ACS Infect Dis; 2016 Jan; 2(1):82-92. PubMed ID: 26771004
[TBL] [Abstract][Full Text] [Related]
4. LPS-binding IgG arrests actively motile Salmonella Typhimurium in gastrointestinal mucus.
Schroeder HA; Newby J; Schaefer A; Subramani B; Tubbs A; Gregory Forest M; Miao E; Lai SK
Mucosal Immunol; 2020 Sep; 13(5):814-823. PubMed ID: 32123309
[TBL] [Abstract][Full Text] [Related]
5. The biophysical principles underpinning muco-trapping functions of antibodies.
Schaefer A; Lai SK
Hum Vaccin Immunother; 2022 Apr; 18(2):1939605. PubMed ID: 34314289
[TBL] [Abstract][Full Text] [Related]
6. SIgA binding to mucosal surfaces is mediated by mucin-mucin interactions.
Gibbins HL; Proctor GB; Yakubov GE; Wilson S; Carpenter GH
PLoS One; 2015; 10(3):e0119677. PubMed ID: 25793390
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
Hendrickx AP; Top J; Bayjanov JR; Kemperman H; Rogers MR; Paganelli FL; Bonten MJ; Willems RJ
mBio; 2015 Nov; 6(6):e01346-15. PubMed ID: 26556272
[TBL] [Abstract][Full Text] [Related]
8. Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A.
Chen A; McKinley SA; Shi F; Wang S; Mucha PJ; Harit D; Forest MG; Lai SK
PLoS One; 2015; 10(7):e0131351. PubMed ID: 26132216
[TBL] [Abstract][Full Text] [Related]
9. Distribution and partial characterisation of IgG Fc binding protein in various mucin producing cells and body fluids.
Kobayashi K; Ogata H; Morikawa M; Iijima S; Harada N; Yoshida T; Brown WR; Inoue N; Hamada Y; Ishii H; Watanabe M; Hibi T
Gut; 2002 Aug; 51(2):169-76. PubMed ID: 12117874
[TBL] [Abstract][Full Text] [Related]
10. Engineering tetravalent IgGs with enhanced agglutination potencies for trapping vigorously motile sperm in mucin matrix.
Shrestha B; Schaefer A; Chavez EC; Kopp AJ; Jacobs TM; Moench TR; Lai SK
Acta Biomater; 2020 Nov; 117():226-234. PubMed ID: 32937206
[TBL] [Abstract][Full Text] [Related]
11. Broadly neutralizing antibodies consistently trap HIV-1 in fresh cervicovaginal mucus from select individuals.
Schaefer A; Yang B; Schroeder HA; Harit D; Humphry MS; Ravel J; Lai SK
Acta Biomater; 2023 Oct; 169():387-397. PubMed ID: 37499728
[TBL] [Abstract][Full Text] [Related]
12. Oligosaccharide side chains on human secretory IgA serve as receptors for ricin.
Mantis NJ; Farrant SA; Mehta S
J Immunol; 2004 Jun; 172(11):6838-45. PubMed ID: 15153502
[TBL] [Abstract][Full Text] [Related]
13. Differential binding of IgG and IgA to mucus of the female reproductive tract.
Fahrbach KM; Malykhina O; Stieh DJ; Hope TJ
PLoS One; 2013; 8(10):e76176. PubMed ID: 24098437
[TBL] [Abstract][Full Text] [Related]
14. Antibody protection from SARS-CoV-2 respiratory tract exposure and infection.
Chen A; Wessler T; Gregory Forest M
J Theor Biol; 2023 Jan; 557():111334. PubMed ID: 36306828
[TBL] [Abstract][Full Text] [Related]
15. Production and secretion of immunoglobulins in the gastrointestinal tract.
Brandtzaeg P; Bjerke K; Kett K; Kvale D; Rognum TO; Scott H; Sollid LM; Valnes K
Ann Allergy; 1987 Nov; 59(5 Pt 2):21-39. PubMed ID: 3318585
[TBL] [Abstract][Full Text] [Related]
16. IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections.
Wang YY; Kannan A; Nunn KL; Murphy MA; Subramani DB; Moench T; Cone R; Lai SK
Mucosal Immunol; 2014 Sep; 7(5):1036-44. PubMed ID: 24496316
[TBL] [Abstract][Full Text] [Related]
17. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice.
Johansen FE; Pekna M; Norderhaug IN; Haneberg B; Hietala MA; Krajci P; Betsholtz C; Brandtzaeg P
J Exp Med; 1999 Oct; 190(7):915-22. PubMed ID: 10510081
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunity: implications for vaccine development.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
[TBL] [Abstract][Full Text] [Related]
19. Commensal bacteria coated by secretory immunoglobulin A and immunoglobulin G in the gastrointestinal tract of pigs and calves.
Tsuruta T; Inoue R; Tsukahara T; Nakamoto M; Hara H; Ushida K; Yajima T
Anim Sci J; 2012 Dec; 83(12):799-804. PubMed ID: 23216546
[TBL] [Abstract][Full Text] [Related]
20. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
